These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 29696816

  • 1. Deletion of Smad4 reduces hepatic inflammation and fibrogenesis during nonalcoholic steatohepatitis progression.
    Qin G, Wang GZ, Guo DD, Bai RX, Wang M, Du SY.
    J Dig Dis; 2018 May; 19(5):301-313. PubMed ID: 29696816
    [Abstract] [Full Text] [Related]

  • 2. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.
    Najt CP, Senthivinayagam S, Aljazi MB, Fader KA, Olenic SD, Brock JR, Lydic TA, Jones AD, Atshaves BP.
    Am J Physiol Gastrointest Liver Physiol; 2016 May 01; 310(9):G726-38. PubMed ID: 26968211
    [Abstract] [Full Text] [Related]

  • 3. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice.
    Zhang J, Zhang H, Deng X, Zhang N, Liu B, Xin S, Li G, Xu K.
    Life Sci; 2018 Jan 01; 192():46-54. PubMed ID: 29158052
    [Abstract] [Full Text] [Related]

  • 4. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP, Stone WC, Karaca FG, Syn WK, Pereira TA, Agboola KM, Omenetti A, Jung Y, Teaberry V, Choi SS, Guy CD, Pollard J, Charlton P, Diehl AM.
    Hepatology; 2009 Nov 01; 50(5):1421-30. PubMed ID: 19676126
    [Abstract] [Full Text] [Related]

  • 5. CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis.
    Rahman SM, Schroeder-Gloeckler JM, Janssen RC, Jiang H, Qadri I, Maclean KN, Friedman JE.
    Hepatology; 2007 May 01; 45(5):1108-17. PubMed ID: 17464987
    [Abstract] [Full Text] [Related]

  • 6. S100A4 Gene is Crucial for Methionine-Choline-Deficient Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.
    Zhang YH, Ma Q, Ding P, Li J, Chen LL, Ao KJ, Tian YY.
    Yonsei Med J; 2018 Nov 01; 59(9):1064-1071. PubMed ID: 30328321
    [Abstract] [Full Text] [Related]

  • 7. Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis.
    Dattaroy D, Pourhoseini S, Das S, Alhasson F, Seth RK, Nagarkatti M, Michelotti GA, Diehl AM, Chatterjee S.
    Am J Physiol Gastrointest Liver Physiol; 2015 Feb 15; 308(4):G298-312. PubMed ID: 25501551
    [Abstract] [Full Text] [Related]

  • 8. Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis.
    Huang R, Guo F, Li Y, Liang Y, Li G, Fu P, Ma L.
    Phytomedicine; 2021 Nov 15; 92():153739. PubMed ID: 34592488
    [Abstract] [Full Text] [Related]

  • 9. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.
    Duan X, Meng Q, Wang C, Liu Z, Liu Q, Sun H, Sun P, Yang X, Huo X, Peng J, Liu K.
    Phytomedicine; 2017 Feb 15; 25():83-92. PubMed ID: 28190475
    [Abstract] [Full Text] [Related]

  • 10. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
    Hu J, Wang H, Li X, Liu Y, Mi Y, Kong H, Xi D, Yan W, Luo X, Ning Q, Wang X.
    Theranostics; 2020 Feb 15; 10(21):9702-9720. PubMed ID: 32863955
    [Abstract] [Full Text] [Related]

  • 11. The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis.
    Barreyro FJ, Holod S, Finocchietto PV, Camino AM, Aquino JB, Avagnina A, Carreras MC, Poderoso JJ, Gores GJ.
    Liver Int; 2015 Mar 15; 35(3):953-66. PubMed ID: 24750664
    [Abstract] [Full Text] [Related]

  • 12. Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice.
    Honda T, Ishigami M, Luo F, Lingyun M, Ishizu Y, Kuzuya T, Hayashi K, Nakano I, Ishikawa T, Feng GG, Katano Y, Kohama T, Kitaura Y, Shimomura Y, Goto H, Hirooka Y.
    Metabolism; 2017 Apr 15; 69():177-187. PubMed ID: 28285648
    [Abstract] [Full Text] [Related]

  • 13. Lipid metabolism, oxidative stress and cell death are regulated by PKC delta in a dietary model of nonalcoholic steatohepatitis.
    Greene MW, Burrington CM, Lynch DT, Davenport SK, Johnson AK, Horsman MJ, Chowdhry S, Zhang J, Sparks JD, Tirrell PC.
    PLoS One; 2014 Apr 15; 9(1):e85848. PubMed ID: 24454937
    [Abstract] [Full Text] [Related]

  • 14. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.
    Xu B, Jiang M, Chu Y, Wang W, Chen D, Li X, Zhang Z, Zhang D, Fan D, Nie Y, Shao F, Wu K, Liang J.
    J Hepatol; 2018 Apr 15; 68(4):773-782. PubMed ID: 29273476
    [Abstract] [Full Text] [Related]

  • 15. Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in mice.
    Zhang N, Wang Y, Zhang J, Liu B, Li G, Xin S, Xu K.
    Mol Med Rep; 2019 Aug 15; 20(2):1363-1372. PubMed ID: 31173200
    [Abstract] [Full Text] [Related]

  • 16. Conophylline inhibits non-alcoholic steatohepatitis in mice.
    Nakade Y, Sakamoto K, Yamauchi T, Inoue T, Kobayashi Y, Yamamoto T, Ishii N, Ohashi T, Sumida Y, Ito K, Nakao H, Fukuzawa Y, Umezawa K, Yoneda M.
    PLoS One; 2017 Aug 15; 12(6):e0178436. PubMed ID: 28594915
    [Abstract] [Full Text] [Related]

  • 17. [The role of Fas mutation on non-alcoholic steatohepatitis in mice].
    Su SS, Han F, Wang RQ, Ren WG, Wu WJ, Kong LB, Zhao SX, Nan YM.
    Zhonghua Gan Zang Bing Za Zhi; 2011 Sep 15; 19(9):653-7. PubMed ID: 22152378
    [Abstract] [Full Text] [Related]

  • 18. Chaihu Guizhi Ganjiang Decoction attenuates nonalcoholic steatohepatitis by enhancing intestinal barrier integrity and ameliorating PPARα mediated lipotoxicity.
    Wu H, Lou T, Pan M, Wei Z, Yang X, Liu L, Feng M, Shi L, Qu B, Cong S, Chen K, Yang H, Liu J, Li Y, Jia Z, Xiao H.
    J Ethnopharmacol; 2024 May 23; 326():117841. PubMed ID: 38310988
    [Abstract] [Full Text] [Related]

  • 19. Caspase 3 inactivation protects against hepatic cell death and ameliorates fibrogenesis in a diet-induced NASH model.
    Thapaliya S, Wree A, Povero D, Inzaugarat ME, Berk M, Dixon L, Papouchado BG, Feldstein AE.
    Dig Dis Sci; 2014 Jun 23; 59(6):1197-206. PubMed ID: 24795036
    [Abstract] [Full Text] [Related]

  • 20. Yellow loosestrife (Lysimachia vulgaris var. davurica) ameliorates liver fibrosis in db/db mice with methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis.
    Son YJ, Jung DS, Shin JM, Kim M, Yoo G, Nho CW.
    BMC Complement Med Ther; 2021 Jan 25; 21(1):44. PubMed ID: 33494735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.